cdmo.directory
← Compare landing

Cell-Easy vs Pluri

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/cell-easy/pluri-biotech

CategoryCell-EasyPluri
Listed sitecdmocdmo
SummaryCell-Easy is a CDMO specializing in development and GMP manufacturing of cell therapies, with expertise across T cells, NK cells, MSCs, and iPSCs. The company has manufactured over 1,000 clinical doses and supports 50+ development programs from process optimization through regulatory compliance.Full-service CDMO specializing in cell therapy manufacturing with GMP facilities, proprietary packed-bed expansion technology, and regulatory approvals from FDA, EMA, PMDA, and other key agencies for clinical-stage production.
Services
  • Cell Therapy Manufacturing
  • Process Development
  • CMC Analytical Development
  • Cell-Line Development
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Cell-Line Development
  • Process Development
  • CMC Analytical Development
  • Formulation Development
  • Technology Transfer
  • Cold-Chain Storage & Logistics
  • Autologous Cell Therapy Manufacturing
  • CMC Regulatory Submission Support
  • Sterile Fill-Finish & Aseptic Manufacturing
Modalities
  • Cell Therapy
  • Cell Therapy
Indications
  • Oncology
  • Immunology
Data not yet provided.
Locations
  • Headquarters, Toulouse, Occitanie, France
  • Headquarters, Haifa, Haifa, Israel
  • USA Office, USA
CertificationsData not yet provided.
  • FDA · Identifier: U.S. Food and Drug Administration
  • EMA · Identifier: European Medicines Agency
  • PMDA · Identifier: Japan's Pharmaceuticals and Medical Devices Agency
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.